What is the market doing?
What the tape says about BIOA
BioAge Labs, Inc. is +128% over the past year while the S&P 500 is +23%: 105 points ahead of the market.
+128%
1-year return · S&P 500 +23%
- vs 200-day average
- −38%
vs 200-day average · a clear downtrend
- RSI (14)
- 36
RSI (14) · neutral
- Below its 52-week high
- −59%
Below its 52-week high
Details›
- Last close2026-08-26
- $9.85
- 1 monthS&P 500 +3.7%
- −55%
- 1 yearS&P 500 +23%
- +128%
- vs 50-day average$16.62
- −41%
- 52-week high
- $24.29
- 52-week low
- $4.33
- Annualised volatility
- 104%
| Year | Return |
|---|---|
| 2026 (year to date) | −26% |
| 2025 | +128% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
The closest names by size in the same industry